Page 4 - Biomedical Technologies News Today

Scoop Community provides New Zealand Community news and views

San Antonio, Texas (PRWEB) January 10, 2022 -- Nvision Biomedical Technologies and Watershed Idea Foundry have received FDA clearance for the first-ever

A novel protein regulator of tumor angiogenesis, TMEM230, was recently characterized by researchers to have a role in tumor development and vascularization, with potential as a target for anti-tumor therapy in difficult-to-treat cancers such as glioblastoma.

QUT scientists have tested in-vitro a promising new concept to treat infection-causing bacterial biofilms on hip replacement implants using a

QUT researchers received $745,623 to develop a new tool for earlier diagnosis of high-risk atheroma, a build-up of plaque in arteries that can lead to

QUT-led research on the interaction between prostate cancer cells and the tumour microenvironment has shed more light on the propensity of some types

Anti-androgen therapy for patients with advanced prostate cancer may fuel bone metastasis Dr Bock, under the mentorship of Distinguished Professor Dietmar Hutmacher, from QUT Centre for Biomedical Technologies, has focused her research on bone metastases from breast and prostate cancers. She developed 3D miniature bone-like tissue models in which 3D printed biomimetic scaffolds are seeded with patient-derived bone cells and tumor cells to be used as clinical and preclinical drug testing tools. ...

Segments Covered By Type, the Machined Bones Allografts segment is estimated to account for the fast-growing segment during the forecasted period. Machined Bones Allografts is considered an effective medical procedure to treat back problems, and it is widely accepted worldwide by patients. Growing willingness in patients to undergo surgery using minimally invasive techniques is driving the growth of the market. By Method, the Minimally Invasive Spine Surgery segment is estimated to account for ...

Multi-Cuvette Spectrophotometer for Life Science Market study formulated by  Data Bridge Market Research, presents a detailed analysis of the influential trends prevailing in this business sphere. The Multi-Cuvette Spectrophotometer for Life Science report provides key strategies followed by leading industry manufacturers, market like production specifications, volume, production value, feasibility analysis, classification based on types and end user application areas with geographic growth a...

Image Credit: Lightspring/Shutterstock.com UK-based Cicada has launched a long-lasting antimicrobial solution to remove COVID on surfaces. The company was established as a subsidiary of an automotive industry specialist Duracare to create safe and COVID-free areas with nanotechnology. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spreads when a person touches contaminated surfaces then directly touches their mouth, nose, or eyes. More than 68 million people have been infected wo...